A 2024 CDC report found that nearly 50% of all drug overdose deaths involved multiple substances. Treatment of Polysubstance use disorder is both complex and challenging in an ever-changing illicit substance climate. Join the ME SUD Learning Community to learn the latest in evidence-based practices for Polysubstance Use Disorder, and best meet the unique needs of patients.

Learning Objectives:

• Participants will explore the current climate of illicit substances
• Participants will examine evidence-based practices that are designed to improve patient retention and treatment outcomes
• Participants will learn how to incorporate trauma-informed, patient-centered, low-barrier practices in the treatment of Polysubstance Use Disorder.

Join us on the 1st and 3rd Thursdays between September 3 and December 3, 2026.

Session 1: September 3 – Stephanie Vail, PharmD, MPH, BCPP, FCCP – Pharmacology Overview of Various Substances
Session 2: September 17 – Ellyse Fredericks – Syringe Redemption
Session 3: October 1 – Josh McQueen, LCSW, LADC, CCS – Contingency Management and Polysubstance Use Disorder
Session 4: October 15 – Rachel Solotaroff, MD, MCR – Polysubstance Withdrawal Management in the Real World: Beyond Protocol Silos
Session 5: November 5 – Eric Haram, LADC – Quality Improvement Strategies for Programs Addressing Substance
Session 6: November 19 – Rachel Solotaroff, MD, MCR – Designing Low-Barrier Withdrawal Management and Alternative Care Pathways
Session 7: December 3 – Kinna Thakarar, DO, MPH and Gregory Dudzik, MD, MPH – Drug Checking